This is the fourth episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Setting the Stage: Effective Onboarding of your AD Patients onto JAK Inhibitor Therapy", featuring expert dermatologist Dr. Ruth Ann Vleugels, MD, MPH discusses the following topics:
- Identifying ideal candidates for oral JAK inhibitor therapy
- Steps to initiate therapy and onboard new patients
- How to manage side effects and maintain adherence to treatment
- Case examples and real-world data
